Legislative Research: US HJR145 | 2023-2024 | 118th Congress
Other Sessions
| Session | Title/Description | Last Action |
|---|---|---|
| 2023-2024 118th Congress (Introduced) | Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests". [HJR145 2023 Detail][HJR145 2023 Text][HJR145 2023 Comments] | 2024-05-16 Referred to the House Committee on Energy and Commerce. |
| 2017-2018 115th Congress (Introduced - Dead) | Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of the Treasury relating to "Returns by Exempt Organizations and Returns by Certain Non-Exempt Organizations". This joint ... [HJR145 2017 Detail][HJR145 2017 Text][HJR145 2017 Comments] | 2018-12-13 Referred to the House Committee on Ways and Means. |
References Online
| Search Phrase | Web | News | Financial | Financial | Encylopedia | Biography | BioGuide |
|---|---|---|---|---|---|---|---|
| [US Congress HJR145] | Google Web | Google News | |||||
| [US Congress House Energy And Commerce Committee] | Google Web | Google News | N/A | ||||
| [Representative Brad Finstad US] | Google Web | Google News | OpenSecrets | FollowTheMoney | Ballotpedia | VoteSmart | BioGuide |
| [Representative Dan Crenshaw US] | Google Web | Google News | OpenSecrets | FollowTheMoney | Ballotpedia | VoteSmart | BioGuide |
| [Representative Pete Sessions US] | Google Web | Google News | OpenSecrets | FollowTheMoney | Ballotpedia | VoteSmart | BioGuide |
| [Representative Jeff Van Drew US] | Google Web | Google News | OpenSecrets | FollowTheMoney | Ballotpedia | VoteSmart | BioGuide |
| [Representative Mariannette Miller-Meeks US] | Google Web | Google News | OpenSecrets | FollowTheMoney | Ballotpedia | VoteSmart | BioGuide |
| [Representative Andy Biggs US] | Google Web | Google News | OpenSecrets | FollowTheMoney | Ballotpedia | VoteSmart | BioGuide |
Legislative Citation
APA
US HJR145 | 2023-2024 | 118th Congress. (2024, May 16). LegiScan. Retrieved July 11, 2024, from https://legiscan.com/US/bill/HJR145/2023
MLA
"US HJR145 | 2023-2024 | 118th Congress." LegiScan. LegiScan LLC, 16 May. 2024. Web. 11 Jul. 2024. <https://legiscan.com/US/bill/HJR145/2023>.
Chicago
"US HJR145 | 2023-2024 | 118th Congress." May 16, 2024 LegiScan. Accessed July 11, 2024. https://legiscan.com/US/bill/HJR145/2023.
Turabian
LegiScan. US HJR145 | 2023-2024 | 118th Congress. 16 May 2024. https://legiscan.com/US/bill/HJR145/2023 (accessed July 11, 2024).
Subjects
Same As/Similar To
| Bill | Relationship | Date | Title | Last Action |
|---|---|---|---|---|
| SJR82 | Same As | 2024-05-15 | A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests". | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-joint-resolution/145/all-info |
| Text | https://www.congress.gov/118/bills/hjres145/BILLS-118hjres145ih.pdf |
